Literature DB >> 20042013

Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.

Teresa C Vieira1, Carla S Bergamin, Lucimary C Gurgel, Regina S Moisés.   

Abstract

Congenital hyperinsulinism of infancy (CHI) is the most common cause of hypoglycemia in newborns and infants. Several molecular mechanisms are involved in the development of CHI, but the most common genetic defects are inactivating mutations of the ABCC8 or KCNJ11 genes. The classical treatment for CHI has been pancreatectomy that eventually leads to diabetes. More recently, conservative treatment has been attempted in some cases, with encouraging results. Whether or not the patients with heterozygous ABCC8 mutations submitted to conservative treatment may spontaneously develop type 2 diabetes in the long run, is a controversial issue. Here, we report a family carrying the dominant heterozygous germ line E1506K mutation in ABCC8 associated with persistent hypoglycemia in the newborn period and diabetes in adulthood. The mutation occurred as a de novo germ line mutation in the mother of the index patient. Her hypoglycemic symptoms as a child occurred after the fourth year of life and were very mild, but she developed glucose metabolism impairment in adulthood. On the other hand, in her daughter, the clinical manifestations of the disease occurred in the neonatal period and were more severe, leading to episodes of tonic-clonic seizures that were well controlled with octreotide or diazoxide. Our data corroborate the hypothesis that the dominant E1506K ABCC8 mutation, responsible for CHI, predisposes to the development of glucose intolerance and diabetes later in life.
© 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20042013     DOI: 10.1111/j.1399-5448.2009.00626.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  14 in total

Review 1.  Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review.

Authors:  Kevin Perge; Marc Nicolino
Journal:  Rev Endocr Metab Disord       Date:  2022-08-23       Impact factor: 9.306

Review 2.  Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.

Authors:  Yisheng Yang; Lawrence Chan
Journal:  Endocr Rev       Date:  2016-04-01       Impact factor: 19.871

3.  Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.

Authors:  Flavio Faletra; Kara Snider; Show-Ling Shyng; Irene Bruno; Emmanouil Athanasakis; Paolo Gasparini; Carlo Dionisi-Vici; Alessandro Ventura; Qing Zhou; Charles A Stanley; Alberto Burlina
Journal:  Gene       Date:  2012-12-22       Impact factor: 3.688

Review 4.  Complex Genetics of Type 2 Diabetes and Effect Size: What have We Learned from Isolated Populations?

Authors:  Anup K Nair; Leslie J Baier
Journal:  Rev Diabet Stud       Date:  2016-02-10

5.  Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations.

Authors:  R R Kapoor; S E Flanagan; C T James; J McKiernan; A M Thomas; S C Harmer; J P Shield; A Tinker; S Ellard; K Hussain
Journal:  Diabetologia       Date:  2011-06-15       Impact factor: 10.122

6.  Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F ABCC8 Mutation

Authors:  Emregül Işık; Hüseyin Demirbilek; Jayne A. Houghton; Sian Ellard; Sarah E. Flanagan; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-03-29

7.  Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation.

Authors:  Akiko Saito-Hakoda; Tohru Yorifuji; Junko Kanno; Shigeo Kure; Ikuma Fujiwara
Journal:  Clin Pediatr Endocrinol       Date:  2012-07-25

8.  ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 Diabetes.

Authors:  Leslie J Baier; Yunhua Li Muller; Maria Sara Remedi; Michael Traurig; Paolo Piaggi; Gregory Wiessner; Ke Huang; Alyssa Stacy; Sayuko Kobes; Jonathan Krakoff; Peter H Bennett; Robert G Nelson; William C Knowler; Robert L Hanson; Colin G Nichols; Clifton Bogardus
Journal:  Diabetes       Date:  2015-08-05       Impact factor: 9.461

9.  Uncovering the molecular pathogenesis of congenital hyperinsulinism by panel gene sequencing in 32 Chinese patients.

Authors:  Zi-Chuan Fan; Jin-Wen Ni; Lin Yang; Li-Yuan Hu; Si-Min Ma; Mei Mei; Bi-Jun Sun; Hui-Jun Wang; Wen-Hao Zhou
Journal:  Mol Genet Genomic Med       Date:  2015-06-29       Impact factor: 2.183

10.  High-frequency actionable pathogenic exome variants in an average-risk cohort.

Authors:  Shannon Rego; Orit Dagan-Rosenfeld; Wenyu Zhou; M Reza Sailani; Patricia Limcaoco; Elizabeth Colbert; Monika Avina; Jessica Wheeler; Colleen Craig; Denis Salins; Hannes L Röst; Jessilyn Dunn; Tracey McLaughlin; Lars M Steinmetz; Jonathan A Bernstein; Michael P Snyder
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.